Sujatha Rochford, PhD* provides strategic counselling to clients in the life science space, primarily managing patent portfolio, conducting due diligence on IP acquisitions, as well as licensing, commercialization and technology transfer for pharmaceutical and biotechnology companies.
Prior to becoming a patent agent, Sujatha began her legal career as a scientific advisor. Her patent prosecution experience includes drafting and prosecuting patents in diverse subject matters that include recombinant protein therapy, small molecules, nanoparticle drug delivery systems, polymers, peptides, soil compositions, dry powder inhalation therapy, molecular diagnostics, flow battery, and oil drilling compositions. Her technical background is in organic and inorganic chemistry, electrochemistry, photovoltaics, renewable energy, materials science, molecular imaging and biotechnology.
Sujatha received her PhD in chemistry from Rutgers University, where she studied the aggregation of custom synthesized molecular dyes at semiconductor surfaces and investigated their interfacial electron transfer processes in dye-sensitized solar cells via electrochemical and photophysical methods. During her postdoctoral studies at University of Pennsylvania, Sujatha synthesized and studied various metal coordination compounds for biomedical imaging applications. Sujatha was a research fellow at Harvard Medical School-Massachusetts General Hospital, where she developed small molecule zinc fluorophores and studied endogenous zinc levels in animal models.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.